BOC Sciences to Present Its Novel Solutions at the 2024 TIDES USA Conference

April 16, 2024 08:00 AM AEST | By EIN Presswire
 BOC Sciences to Present Its Novel Solutions at the 2024 TIDES USA Conference
Image source: EIN Presswire
NEW YORK CITY, NEW YORK, UNITED STATES, April 15, 2024 /EINPresswire.com/ -- BOC Sciences, a globally renowned supplier with over a decade of experience in the biochemical supply chain, is thrilled to announce its participation in this year's TIDES USA or the Oligonucleotide and Peptide Therapeutics conference. The BOC Sciences team will showcase its cutting-edge products and services at booth #937.

TIDES USA 2024 is to be held in Boston from May 14 to 17, 2024, gathering industry leaders across the biotechnology and pharmaceutical landscape. It's regarded as the largest and most renowned event in the industry to accelerate oligo and peptide therapeutics to market.

BOC Sciences has been a part of the exhibitor list for several years, with footprints over TIDES Europe and USA. This year, BOC Sciences plans to bring some previous exhibits as well as some innovations.

"For us, Tides USA serves as a perfect platform to engage with our peers, share insights, and learn about the latest industry trends. My team is eager to connect with other recognized global representatives to foster a dialogue about the future of the biomedical field", said the chief scientific officer at BOC Sciences.

BOC Sciences, with its focus on chemical manufacturing and CRO services, is perfectly poised to shed light on the role that its chemical materials and technologies play in advancing biomedical innovations. Visitors at booth #937 can expect to get an up-close look at some of the groundbreaking work that BOC Sciences has been doing.

BOC Sciences 2024 exhibition highlights include Nucleosides, Phosphoramidites, Inhibitors, Vaccine Adjuvants, RNAi Products, Impurities, Carbohydrates, and Building Blocks. And not just in complex chemicals, BOC Sciences' expertise and capabilities also run across comprehensive options of custom synthesis and various types of drug discovery services. Its one-stop fermentation CDMO services can cover every step from custom project design, strain selection and optimization, fermentation production, and packaging. Its newly launched XDC bioconjugation platform greatly addresses research needs in diverse bioconjugates.

BOC Sciences invites attendees to join them at booth #937 for a robust discussion around their progress and challenges in oligonucleotide, mRNA, or peptide development. How can the biotech company aid in the continued development of these exciting fields? That will be the central topic of the talks there.

For more information about BOC Sciences at TIDES USA 2024, please visit its website.

About BOC Sciences
BOC Sciences is a biotech company that has combined the power of advanced engineering with years of experience to manufacture thousands of (bio)chemicals. It also provides a wide range of services to support the pharmaceutical industry through the early stages of drug discovery and development. It is now a brand trusted by many in the scientific community due to its reliable offerings and commitment to the advancement of science.

Alex Brown
BOC Sciences
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.